Literature DB >> 15878621

Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.

Richard De La Garza1.   

Abstract

In humans, exposure to endotoxins or pro-inflammatory cytokines induces a number of neuropsychological symptoms collectively referred to as 'flu-like syndrome'. The degree of overlap between flu-like syndrome and major depressive disorder is considerable and a close linkage between these has been predicted to arise due to hypersecretion of endogenous pro-inflammatory cytokines and activation of the hypothalamic pituitary adrenal axis. In animals, exposure to pro-inflammatory cytokines or endotoxins induces a 'sickness behavior' syndrome that is analogous to flu-like symptoms observed in human patients. The goal of the current paper is to review evidence implicating endotoxin- or cytokine-induced sickness behavior as an animal model of depression, with an emphasis on reduced consumption of highly palatable substances as a defining feature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878621     DOI: 10.1016/j.neubiorev.2005.03.016

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  44 in total

1.  Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes.

Authors:  Jonathan A Shaffer; Donald Edmondson; William F Chaplin; Joseph E Schwartz; Daichi Shimbo; Matthew M Burg; Nina Rieckmann; Karina W Davidson
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

2.  The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health.

Authors:  Angela J Grippo
Journal:  Soc Personal Psychol Compass       Date:  2011-04

Review 3.  Neonatal programming of innate immune function.

Authors:  S J Spencer; M A Galic; Q J Pittman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

4.  Long-term cocaine self-administration under fixed-ratio and second-order schedules in monkeys.

Authors:  Paul W Czoty; Beth A Reboussin; Tonya L Calhoun; Susan H Nader; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2007-01-10       Impact factor: 4.530

5.  Isolation rearing impairs wound healing and is associated with increased locomotion and decreased immediate early gene expression in the medial prefrontal cortex of juvenile rats.

Authors:  J B Levine; A D Leeder; B Parekkadan; Y Berdichevsky; S L Rauch; J W Smoller; C Konradi; F Berthiaume; M L Yarmush
Journal:  Neuroscience       Date:  2007-10-24       Impact factor: 3.590

6.  How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry.

Authors:  Su-Mi Park; Ron P A Gaykema; Lisa E Goehler
Journal:  Brain Behav Immun       Date:  2008-06-17       Impact factor: 7.217

Review 7.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

8.  Inflammation and dimensions of reward processing following exposure to the influenza vaccine.

Authors:  Chloe C Boyle; Kate R Kuhlman; Larissa N Dooley; Marcie D Haydon; Theodore F Robles; Yuen-Siang Ang; Diego A Pizzagalli; Julienne E Bower
Journal:  Psychoneuroendocrinology       Date:  2018-11-20       Impact factor: 4.905

9.  Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions.

Authors:  Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay
Journal:  World J Biol Psychiatry       Date:  2018-08-16       Impact factor: 4.132

10.  Allergy: a risk factor for suicide?

Authors:  Teodor T Postolache; Hirsh Komarow; Leonardo H Tonelli
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.